Artemis Iatrou

Assistant Professor

Boston University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

The dorsolateral prefrontal cortex (dlPFC) controls many cognitive and emotional processes that are disrupted in schizophrenia (SCZ). However, the spatial location of molecular changes associated with SCZ within the dlPFC remains poorly characterized. dlPFC cell types are spatially organized across six layers into microcircuits that mediate dlPFC function. While SCZ has been linked to regionally-defined cell types, spatially-resolved transcriptomics (SRT) can more directly map molecular associations of disease. We integrated protein detection for perineuronal nets, neurons and vasculature with SRT to investigate how gene expression varies across different cellular microenvironments in the human dlPFC from neurotypical control (n=31) and SCZ (n=32) brain donors. We mapped transcriptional alterations in synaptic, neuroimmune and metabolic pathways to neuropil and glia-enriched domains including the white matter. Integrative analyses linked laminar alterations predominantly to non-neuronal populations, and in situ profiling further resolved these changes at cellular resolution, indicating intracellular transcriptional changes that may underpin SCZ-associated alterations. By mapping SCZ-associated ligand-receptor pairs, we curated altered patterns of cell-cell communication that may coordinate local signaling dynamics across specialized tissue microenvironments. Finally, analyses that integrate SCZ genetic risk further highlight the significance of neuron-glia interactions, suggesting that neuronal genetic liability may signal through non-neuronal alterations across cortical domains. This multimodal atlas provides a spatial-anatomical framework for linking genetic risk to transcriptional phenotypes in the human cortex, delineating SCZ-associated gene expression landscapes across layers, single cells, and microenvironments. The data is available as a browsable PsychENCODE resource to support broad utilization that can inform mechanistic studies investigating SCZ pathology and risk.

Year:

2026

The molecular pathology of stress-related disorders remains elusive. Our brain multiregion, multiomic study of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) included the central nucleus of the amygdala, hippocampal dentate gyrus, and medial prefrontal cortex (mPFC). Genes and exons within the mPFC carried most disease signals replicated across two independent cohorts. Pathways pointed to immune function, neuronal and synaptic regulation, and stress hormones. Multiomic factor and gene network analyses provided the underlying genomic structure. Single nucleus RNA sequencing in dorsolateral PFC revealed dysregulated (stress-related) signals in neuronal and non-neuronal cell types. Analyses of brain-blood intersections in >50,000 UK Biobank participants were conducted along with fine-mapping of the results of PTSD and MDD genome-wide association studies to distinguish risk from disease processes. Our data suggest shared and distinct molecular pathology in both disorders and propose potential therapeutic targets and biomarkers.

Year:

2024

The gene signatures of Alzheimer’s Disease (AD) brains reflect an output of a complex interplay of genetic, epigenetic, epi-transcriptomic, and post-transcriptional regulations. To identify the most significant factor that shapes the AD brain signature, we developed a machine learning model (DEcode-tree) to integrate cellular and molecular factors explaining differential gene expression in AD. Our model indicates that YTHDF proteins, the canonical readers of N6-methyladenosine RNA modification (m6A), are the most influential predictors of the AD brain signature. We then show that protein modules containing YTHDFs are downregulated in human AD brains, and knocking out YTHDFs in iPSC-derived neural cells recapitulates the AD brain gene signature in vitro . Furthermore, eCLIP-seq analysis revealed that YTHDF proteins influence AD signatures through both m6A-dependent and independent pathways. These results indicate the central role of YTHDF proteins in shaping the gene signature of AD brains.

Year:

2024

Amyloid-beta (Aβ) plaques and surrounding glial activation are prominent histopathological hallmarks of Alzheimer’s Disease (AD). However, it is unclear how Aβ plaques interact with surrounding glial cells in the human brain. Here, we applied spatial transcriptomics (ST) and immunohistochemistry (IHC) for Aβ, GFAP, and IBA1 to acquire data from 258,987 ST spots within 78 postmortem brain sections of 21 individuals. By coupling ST and adjacent-section IHC, we showed that low Aβ spots exhibit transcriptomic profiles indicative of greater neuronal loss than high Aβ spots, and high-glia spots present transcriptomic changes indicative of more significant inflammation and neurodegeneration. Furthermore, we observed that this ST glial response bears signatures of reported mouse gene modules of plaque-induced genes (PIG), oligodendrocyte (OLIG) response, disease-associated microglia (DAM), and disease-associated astrocytes (DAA), as well as different microglia (MG) states identified in human AD brains, indicating that multiple glial cell states arise around plaques and contribute to local immune response. We then validated the observed effects of Aβ on cell apoptosis and plaque-surrounding glia on inflammation and synaptic loss using IHC. In addition, transcriptomic changes of iPSC-derived microglia-like cells upon short-interval Aβ treatment mimic the ST glial response and mirror the reported activated MG states. Our results demonstrate an exacerbation of synaptic and neuronal loss in low-Aβ or high-glia areas, indicating that microglia response to Aβ-oligomers likely initiates glial activation in plaque-glia niches. Our study lays the groundwork for future pathology genomics studies, opening the door for investigating pathological heterogeneity and causal effects in neurodegenerative diseases.

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Stephanie Hicks

Associate Professor

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES
View details

Keri Martinowich

-

UNITED STATES
View details

Nikolaos Daskalakis

Associate member

Harvard Medical School

UNITED STATES
View details

Jakob Hartmann

Harvard University

UNITED STATES
View details

Diego Mastroeni

Associate Proffessor

Arizona State University

UNITED STATES
View details

Shizhong Han

Lead Investigator

Johns Hopkins University School of Medicine

UNITED STATES
View details

Leonardo Collado-Torres

Assistant Professor

Johns Hopkins University

UNITED STATES
View details

Boyi Guo

Assistant Professor

University of Utah Health

UNITED STATES
View details

Yanling Wang

Associate Professor

Rush University Medical Center

UNITED STATES
View details